Avenzo and Gilead partner for breast cancer combination regimen trial
Avenzo will be responsible for conducting and sponsoring the combination study.
04 September 2024
04 September 2024
Avenzo will be responsible for conducting and sponsoring the combination study.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.